Santhera Pharmaceuticals’ CHF69 Million Royalty And Debt Financing

Homburger advised Santhera Pharmaceuticals Holding AG on the deal.Santhera Pharmaceuticals Holding AG (SIX: SANN) entered into a royalty monetization financing totaling up to USD 38 m…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

This content is for Standard 1 Year members only.
Login Join Now